Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment

Brain Behav Immun. 2019 Jul;79:319-325. doi: 10.1016/j.bbi.2019.04.005. Epub 2019 Apr 3.

Abstract

Cancer and its treatment are associated with neurotoxic side effects, including cognitive dysfunction, altered functional connectivity in the brain and structural abnormalities in white matter. There is evidence that cancer and its treatment can accelerate aging. Tau is a microtubule associated protein that contributes to microtubule stability thereby playing a key role in neuronal function. Clustering of tau is commonly observed in the aged brain and is related to cognitive decline. We hypothesized that chemotherapy-induced cognitive impairment is associated with accelerated development of tau clustering in the brain as a sign of accelerated aging. We show for the first time that treatment of adult (7-8 month-old) male C57BL/6 mice with cisplatin results in reduced cognitive function and a marked increase in the number of large endogenous tau clusters in the hippocampus when assessed 4 months later. In contrast, we detected only few small tau clusters in the hippocampus of age-matched 11-12 month-old control mice. Astrocyte GFAP expression was increased in close vicinity to the tau clusters in cisplatin-treated mice. We did not detect changes in the microglial marker Iba-1 in the brain of mice treated with cisplatin. The accelerated formation of Tau-1 clusters in cisplatin-treated mice was associated with a decrease in the levels of the post-synaptic marker PSD95 and of the presynaptic marker synaptophysin in the hippocampus. We demonstrate here for the first time that chemotherapy markedly accelerates development of signs of tauopathy and loss of synaptic integrity in the hippocampus. These findings provide a mechanistic link between chemotherapy cognitive decline and accelerated aging in cancer survivors.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Age Factors
  • Aging / metabolism
  • Animals
  • Brain / metabolism
  • Cisplatin / adverse effects*
  • Cognition / drug effects
  • Cognitive Dysfunction / etiology
  • Cognitive Dysfunction / metabolism*
  • Disease Models, Animal
  • Drug Therapy
  • Drug-Related Side Effects and Adverse Reactions
  • Glial Fibrillary Acidic Protein / analysis
  • Glial Fibrillary Acidic Protein / drug effects
  • Hippocampus / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Tauopathies / etiology
  • Tauopathies / metabolism*
  • tau Proteins / metabolism

Substances

  • Glial Fibrillary Acidic Protein
  • glial fibrillary astrocytic protein, mouse
  • tau Proteins
  • Cisplatin